Page last updated: 2024-08-26

sr141716 and Hypercholesterolemia

sr141716 has been researched along with Hypercholesterolemia in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Botha, AJ; Crook, MA; Dar, A; McMahon, Z; Oben, J; Pendleton, S; Wierzbicki, AS1
Acharya, A; Balaraman, R; Chatterjee, A; Jain, MR; Mohapatra, J; Pandya, G; Sharma, M1
Schaerlig, E1
Nau, JY1

Other Studies

4 other study(ies) available for sr141716 and Hypercholesterolemia

ArticleYear
Rimonabant improves cholesterol, insulin resistance and markers of non-alcoholic fatty liver in morbidly obese patients: a retrospective cohort study.
    International journal of clinical practice, 2011, Volume: 65, Issue:6

    Topics: Adult; Biomarkers; Cannabinoid Receptor Modulators; Cholesterol; Fatty Liver; Female; Humans; Hypercholesterolemia; Insulin Resistance; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Obesity, Morbid; Piperidines; Pyrazoles; Retrospective Studies; Rimonabant; Safety-Based Drug Withdrawals; Triglycerides; Weight Loss

2011
Retinol-binding protein 4 : a possible role in cardiovascular complications.
    British journal of pharmacology, 2011, Volume: 164, Issue:8

    Topics: 3T3-L1 Cells; Adipokines; Animals; Apolipoprotein E3; Atherosclerosis; Base Sequence; Cardiovascular Diseases; Cholesterol; DNA Primers; Female; Gene Expression Regulation; Hypercholesterolemia; Inflammation; Mice; Mice, Inbred C57BL; Obesity; Piperidines; Pyrazoles; Real-Time Polymerase Chain Reaction; Retinol-Binding Proteins, Plasma; Rimonabant

2011
[Highlights from the American College of Cardiology Annual Scientific Session 2005: March 5-9, 2005, Orlando, Florida].
    Revue medicale suisse, 2005, May-04, Volume: 1, Issue:18

    Topics: Aspirin; Cardiovascular Diseases; Cholesterol, LDL; Clopidogrel; Humans; Hypercholesterolemia; Obesity; Piperidines; Platelet Aggregation Inhibitors; Pyrazoles; Rimonabant; Stroke; Ticlopidine

2005
[The formidable virtue announced for rimonabant, alias Acomplia].
    Revue medicale suisse, 2005, Nov-30, Volume: 1, Issue:43

    Topics: Humans; Hypercholesterolemia; Piperidines; Pyrazoles; Rimonabant

2005